Developing novel therapeutics for the treatment of rare diseases.

Pages

News and Events

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics Announces Financing Commitment for up to $60 Million

Contact Us

  • 203 Redwood Shores Parkway
  • Suite 500
  • Redwood City, CA 94065